UNJHAFOR logo

Unjha Formulations Ltd

UNJHAFOR·BSE·
30.64 +1.45 (+4.97%)
Market Cap12.46 Cr
PE Ratio33.30
Volume15,131
Day High - Low30.64 - 30.50
52W High-Low30.64 - 17.52
DocStoX Score
6.0/10
Fair
Fair Value
Sign in to see
ROE
20.10%
Strong
P/E
33.30x
Fair
Debt / Equity
0.00
Low
Industry
Healthcare
Pharmaceuticals
Overall View
Fair

Price performance

Day30.50
30.64
52W17.52
30.64
DocStoX take

Supported by growth (8.0) and momentum (7.5), but held back by valuation (3.3).

DocStoX score

Low confidence
6.0
/10
Fair
Quality
Solid
ROE 20.1%
Valuation
Rich
P/E 33.3×
Growth
Strong
Revenue +9.5% 5Y CAGR
Risk
Moderate
D/E 0.00
Momentum
Strong
100% of 52-week range

At a glance

Market Cap
₹12 Cr
52W High / Low
₹31 / ₹18
Dividend Yield
0.00%
Promoter Holding
36.92%
EPS (TTM)
₹0.92
Book Value
₹8.58

Key highlights

  • Profit compounding 48% a year
  • Low leverage — D/E 0.00
  • Profitable in all of the last 5 years
  • Small ₹12 cr company — thinner liquidity
4 Positives1 Watchout

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Pharmaceuticals

Unjha Formulations Ltd peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.